Atelerix Forges Key Alliance with JH Health to Revolutionize Cell Preservation in the Middle East
Riyadh, Saudi Arabia – In a significant move poised to transform biological transport and cell preservation, Atelerix, a pioneering biotech firm renowned for its hydrogel encapsulation technology, has officially announced a strategic partnership with JH Health Ltd. Based in Saudi Arabia, JH Health is a prominent player in medical and health-related technology, making this collaboration a pivotal step for both entities.
Expanding Global Reach and Regional Capabilities
This landmark agreement grants JH Health exclusive rights to deploy and distribute Atelerix’s cutting-edge hydrogel-based cell and tissue preservation solutions across the Middle East. This strategic alliance is set to substantially enhance Atelerix’s global commercial footprint by establishing new regional manufacturing and distribution channels, addressing the escalating worldwide demand for its innovative technology.
Atelerix’s growth trajectory has consistently focused on forging strategic partnerships to embed local technical expertise and ensure regional supply in crucial markets, including China, Europe, and Africa. The latest collaboration with JH Health is particularly noteworthy, as it unlocks extensive networks and distribution channels essential for penetrating the Middle East’s rapidly expanding life science and healthcare sectors.
Advancing Clinical Diagnostics and Research
The partnership’s primary objective is to facilitate the stable and efficient transport of patient-derived biological samples, crucial for clinical diagnostics and a wide array of research applications. A key initiative under this alliance will be the development of a new biobank within the region, further solidifying the Middle East’s position in advanced biomedical research.
Locally supported by JH Health, Atelerix will spearhead the regulatory approval processes for its technology with the Saudi Food and Drug Authority. Furthermore, JH Health will provide vital financial backing and strategic guidance to scale up Atelerix’s operations in the region. This includes fostering local capabilities for high-volume manufacturing and cultivating new research partnerships to advance hypothermic preservation technology.
The Power of Hydrogel Technology
Atelerix’s proprietary hydrogel technology represents a paradigm shift in biological sample preservation. By physically encapsulating sensitive cells and tissues within a soft hydrogel matrix, the technology effectively stabilizes membrane integrity. This ingenious method allows samples to be stored at ambient temperatures for up to two weeks, thereby eliminating the prohibitive costs and logistical complexities associated with traditional cold chain transport and mitigating the loss of sample viability often encountered with cryopreservation.
Leadership Voices on the Partnership
Alastair Carrington, CEO of Atelerix, expressed his enthusiasm: “By partnering with JH Health, we gain access to the deep market expertise and local support needed to establish our operations in the Middle East. Their strategic investment will enable us to build out our local manufacturing capabilities, ensuring we are equipped to deliver the future of biological transport logistics and meet the needs of the rapidly growing life science market in the region. This partnership is an integral next step in our strategy to bring our advanced cell preservation solutions to customers, worldwide.”
Echoing this sentiment, Mohammed Al Jumah, CEO of JH Health, stated: “We are delighted to establish a strategic partnership with Atelerix to bring advanced biosample preservation technologies to the Middle East. By combining Atelerix’s pioneering solutions with our regional expertise, this collaboration enhances access to advanced tools that support biomedical research, accelerate scientific discovery, and strengthen clinical development across the region, ultimately improving healthcare outcomes.”
This collaboration marks a significant milestone in bringing advanced, non-cryogenic cell preservation solutions to a crucial and expanding global market, promising enhanced research capabilities and improved healthcare delivery.
#Atelerix #JHHealth #CellPreservation #BiotechPartnership #MiddleEastHealthcare #HydrogelTechnology #LifeScience #MedicalInnovation #NonCryogenic #Biobanking